by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Moderna Stock Outlook: Cash Crunch, Cancer Hopes, and Key Levels Ahead of Earnings The Moderna stock outlook is on a knife-edge this week as investors brace for Thursday’s earnings report. Once flush with nearly $20 billion in pandemic profits, the biotech innovator... by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Robinhood Stock Prediction Markets Fuel Explosive Growth — What Traders Should Know Robinhood Markets Inc. reported record-breaking third-quarter results as its aggressive push into Robinhood stock prediction markets and crypto trading drove massive new engagement and... by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Brazil’s Amazon Potash Mine Aims to Secure Fertilizer Independence Amid Global Trade Shifts Deep within the Amazon rainforest, a massive mining project is taking shape that could redefine Brazil’s agricultural future. Near the town of Autazes, workers are preparing to... by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Novo Nordisk Cuts 2025 Guidance as GLP-1 Momentum Cools; Stock Slips After Q3 Miss Novo Nordisk (NVO) shares fell after the Danish drugmaker posted a third-quarter miss and trimmed its 2025 outlook, underscoring investor anxiety that the company’s GLP-1 juggernaut is... by ADRIAN MANZ | Nov 5, 2025 | The Doctor's Dose
Bank of America Stock Slides Despite Higher Profit Targets at First Investor Day Since 2011 Bank of America (BAC) shares fell on Wednesday even as the bank’s leadership raised profitability and growth targets during its first investor day in 14 years. The event, held... by ADRIAN MANZ | Nov 4, 2025 | The Doctor's Dose
S&P 500 and Nasdaq Post Biggest Drop in Nearly a Month The S&P 500 and Nasdaq Composite recorded their sharpest one-day declines in nearly a month on Wednesday, as Wall Street investors rotated out of high-flying technology and AI stocks amid growing caution... by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Core Scientific Shareholders Reject $9 Billion Merger with CoreWeave Core Scientific shareholders have voted down a $9 billion all-stock merger with CoreWeave, abruptly ending one of the most closely watched transactions in the AI data center sector. The vote, which... by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Google, Meta, and Microsoft Spend $80 Billion on AI as Investor Reactions Diverge Google, Meta, and Microsoft collectively spent almost $80 billion last quarter on artificial intelligence infrastructure — a record-breaking wave of investment that drew starkly... by ADRIAN MANZ | Oct 30, 2025 | The Doctor's Dose
Meta Plans $25 Billion Bond Sale to Fund Soaring AI Infrastructure Costs Meta Platforms is preparing to raise as much as $25 billion in one of the largest corporate bond sales of the year, as the company accelerates spending to expand its artificial intelligence... by ADRIAN MANZ | Oct 29, 2025 | The Doctor's Dose
Future Fed Rate Cuts ‘Far’ From Certain After a Divided Meeting The Federal Reserve delivered a second straight 25 bp rate cut, trimming the federal-funds target range to 3.75%–4.00%. But Chair Jerome Powell used the press conference to puncture confidence in another... 